| Literature DB >> 1464358 |
Abstract
Facilities for radiolabelling and gamma scintigraphy are largely restricted to nuclear medicine departments or specialised research institutions and are therefore not widely available to workers in cancer research. Despite this, there is growing interest in gamma scintigraphy, which can provide information relevant to the entire field of cancer immunology. This review discusses the present and future roles of gamma scintigraphy in respect of antibody-targeted, cell-mediated and cytokine therapy. The authors aim to show that gamma scintigraphy is an investigative tool of great potential.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1464358 DOI: 10.1007/bf00180868
Source DB: PubMed Journal: Eur J Nucl Med ISSN: 0340-6997